The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
Disorders of the metabolism, including obesity and type 2 diabetes, represent significant global health challenges due to their rising prevalence and associated complications. Despite existing therapeutic strategies, including lifestyle interventions, pharmacological treatments, and surgical options...
Saved in:
| Main Author: | Scott Mendoza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AIMS Press
2025-03-01
|
| Series: | AIMS Neuroscience |
| Subjects: | |
| Online Access: | https://www.aimspress.com/article/doi/10.3934/Neuroscience.2025003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants
by: Cristina Sempio, et al.
Published: (2024-11-01) -
Síndrome de hiperémesis cannabinoide: una revisión
by: R.A. Jiménez-Castillo, et al.
Published: (2025-04-01) -
Cannabinoid hyperemesis syndrome: A review
by: R.A. Jiménez-Castillo, et al.
Published: (2025-04-01) -
Cannabinoids and the endocannabinoid system in the regulation of cytochrome P450 metabolic activity-a review
by: Carlos D.F. Fonseca, et al.
Published: (2025-06-01) -
Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis
by: Yaqian Tan, et al.
Published: (2025-04-01)